CSX vs ENTA · P/E 19, rev $14.09B vs rev $65.3M
CSX Corporation (CSX) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the CSX and ENTA stock pages for the full models.
Not investment advice.